Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Lung Cancer Drug Doubles Benefit, Researchers Say
Bloomberg
Sunday, September 30, 2012 - 10:36am
tags:
Pfizer, Xalkori, lung cancer
Peregrine: Investors are Shocked Over This Murky Future
Wall Street Cheat Street
Sunday, September 30, 2012 - 10:35am
tags:
Peregrine Pharmaceuticals
Medivation and Astellas Announce New Data From XTANDI(R) (enzalutamide) Pivotal Study
Yahoo/MarketWire
Sunday, September 30, 2012 - 10:34am
tags:
Astellas, Medivation, Enzalutamide, prostate cancer
Threshold Pharmaceuticals Announces Preliminary Data From Phase 1/2 Study of TH-302 in Combination With Bevacizumab in Patients With Recurrent Glioblastoma
Yahoo/MarketWire
Sunday, September 30, 2012 - 10:33am
tags:
glioblastoma, bevacizumab, TH-302, Threshold Pharmaceuticals
Preliminary Phase 1 Data for Cabozantinib in Japanese Patients Presented at ESMO 2012
Yahoo/BusinessWire
Sunday, September 30, 2012 - 10:31am
tags:
cabozantinib, Exelixis, solid tumors
Dividend? Buyback? Let's Do Both!
Motley Fool
Sunday, September 30, 2012 - 10:30am
tags:
Questcor Pharmaceuticals
Dendreon Makes Progress, but Issues May Loom
Motley Fool
Sunday, September 30, 2012 - 10:29am
tags:
Dendreon
Why the Street Should Love ViroPharma's Earnings
Motley Fool
Sunday, September 30, 2012 - 10:28am
tags:
ViroPharma
Teva acquires Huntexil development programme rights from NeuroSearch
Pharmabiz
Saturday, September 29, 2012 - 12:58pm
tags:
Teva Pharmaceuticals, Huntexil, Neurosearch, Huntington's disease
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
Enhanced Online News
Saturday, September 29, 2012 - 12:57pm
tags:
levomilnacipran, major depressive disorder, biopolar depression, Forest Labs
7 Pharmaceutical Stocks to Buy Now
InvestorPlace
Saturday, September 29, 2012 - 12:56pm
tags:
Novartis, Eli Lilly, Merck, Pfizer, Acura Pharmaceuticals, SciClone Pharmaceuticals, Lannett
New Jersey initiates $2.6M retraining grant to stem big pharma brain drain
Med City News
Saturday, September 29, 2012 - 12:54pm
tags:
Progenics Pharmaceuticals Initiates Phase 2 Clinical Trial of PSMA ADC in Prostate Cancer Patients
Pipeline Review
Saturday, September 29, 2012 - 12:41pm
tags:
Progenics, PSMA ADC, prostate cancer
Pipeline Progress at BioMarin
Zacks
Saturday, September 29, 2012 - 12:36pm
tags:
BMN-111, Peg-Pal, dwarfism, phenylketonuria, Biomarin
Is Valeant Shopping 'Til It Drops?
Daily Finance
Saturday, September 29, 2012 - 12:33pm
tags:
Valeant Pharmaceuticals, M&A
OncoGenex Announces Initiation Of A Phase 3 Trial For Custirsen In Advanced Non-Small Cell Lung Cancer
Sacramento Bee, CA
Saturday, September 29, 2012 - 12:32pm
tags:
non-small cell lung cancer, custirsen, OncoGenex
6 Pharmaceutical Stocks to Sell Now
InvestorPlace
Saturday, September 29, 2012 - 12:30pm
tags:
Warner Chilcott, Hi Tech Pharmacal, Optimer Pharmaceuticals, Avanir, Pemix Therapeutic Holdings, Horizon Pharma
Dr. Reddy’s Announces the Launch of Montelukast Sodium Oral Granules
Enhanced Online News
Saturday, September 29, 2012 - 12:28pm
tags:
Dr Reddy's, Singulair, generics
Should Investors Be Angry With Big Pharma?
Motley Fool
Saturday, September 29, 2012 - 12:27pm
tags:
This Drug Could Be a Game-Changer for Sarepta (and a Savior for Thousands)
Motley Fool
Saturday, September 29, 2012 - 12:26pm
tags:
Sarepta Therapeutics, muscular dystrophy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.